Charles River Laboratories (CRL)
- Exchange
- NYSE
- Symbol
- CRL
- Sector
- Trade & Services
- Industry
- Services-commercial Physical & Biological Research
- Description
- Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
- Country
- USA
Stock price
At close: December 20, 2024
-
Open181.54
-
High188.04
-
Low181.29
-
Close185.77
-
Volume1,139,340
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
3.61
Receivables turnover
5.25
Payables turnover
8.12
Working capital turnover
7.40
Days of inventory on hand (DOH)
101.16
Days of sales outstanding (DSO)
69.52
Number of days of payables
44.94
Fixed asset turnover
2.50
Total asset turnover
0.50
Current ratio
1.52
Quick ratio
1.00
Cash ratio
0.26
Cash conversion cycle
125.74
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.28
Interest coverage
5.21
Gross profit margin
66.51%
Operating profit margin
15.07%
Pretax margin
14.05%
Net profit margin
11.58%
Operating return on assets (Operating ROA)
7.53%
Return on assets (ROA)
5.79%
Return on total capital
19.80%
Return on equity (ROE)
13.20%